Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Other acantholytic disorders |
French
|
Autres acantholyses |
| Level | Code | Title | |
|---|---|---|---|
| 1 | XII | Diseases of the skin and subcutaneous tissue | |
| 2 | L10-L14 | Bullous disorders | |
| 3 | L11 | Other acantholytic disorders |
| Code | Title | |
|---|---|---|
| L11.0 | Acquired keratosis follicularis | |
| L11.1 | Transient acantholytic dermatosis [Grover] | |
| L11.8 | Other specified acantholytic disorders | |
| L11.9 | Acantholytic disorder, unspecified |
| Active Ingredient | Description | |
|---|---|---|
| Dexpanthenol |
Dexpanthenol is converted in tissues to pantothenic acid, a component of coenzyme A (CoA) that is essential to normal epithelial function, increased fibroblast proliferation and accelerated re-epithelialization in wound healing. |
|
| Ingenol mebutate |
Picato is indicated for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults. The mechanism of action of ingenol mebutate for use in actinic keratosis remains to be fully characterised. Results from two clinical studies on biological effects of ingenol mebutate have shown that topical administration induced epidermal necrosis and a profound inflammatory response in both epidermis and the upper dermis of the treated skin, dominated by infiltrating T cells, neutrophils and macrophages. |
